English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18074/20272 (89%)
造訪人次 : 4072734      線上人數 : 925
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34336


    標題: Cell suspension culture extract of Eriobotrya japonica attenuates growth and induces apoptosis in prostate cancer cells via targeting SREBP-1/FASN-driven metabolism and AR
    作者: Hsieh, Po-Fan
    Jiang, Wen-Ping
    Basavaraj, Praveenkumar
    Huang, Shih-Yin
    Ruangsai, Phakkhathorn
    Wu, Jin-Bin
    Huang, Guan-Jhong
    Huang, Wen-Chin
    貢獻者: China Med Univ, Sch Med, Grad Inst Biomed
    China Med Univ Hosp, Dept Urol
    China Med Univ, Sch Med
    China Med Univ, Coll Chinese Med, Sch Chinese Pharmaceut Sci & Chinese Med Resource
    Chia Nan Univ Pharm & Sci, Dept Pharm
    Asia Univ, Dept Occupat Therapy
    China Med Univ, Sch Med, Int Masters Program Biomed Sci
    Nihon Pharmaceut Univ
    Asia Univ, Dept Hlth & Nutr Biotechnol
    關鍵字: Eriobotrya japonica
    Sterol regulatory element-binding protein-1
    Fatty acid synthase
    Androgen receptor
    Apoptosis
    日期: 2021
    上傳時間: 2023-11-11 11:44:23 (UTC+8)
    出版者: ELSEVIER GMBH
    摘要: Background: Castration-resistant prostate cancer (CRPC) is one of the main causes of male cancer mortality. There is currently no effective treatment to cure this deadly prostate cancer (PCa) progression. However, recent research showed that activation of lipogenesis leads to CRPC progression. It provides a rationale to target the highly lipogenic activity as a novel and promising therapy against lethal CRPC. Purposes: The present study aims to evaluate the anticancer efficacy and the molecular mechanism of cell suspension culture extract from Eriobotrya japonica (EJCE) in PCa, including CRPC. Methods: Cell growth, migration and invasion analyses were performed by MTT method, a wound healing assay and the transwell method, respectively. Apoptosis was assessed by a flow cytometry-based Annexin V-FITC/PI assay, caspase enzymatic activity and Western blot analyses. Lipogenesis was determined by a Fatty Acid Quantification Kit and an Oil Red O staining. The in vivo experiment was conducted by a xenograft mouse model. Results: PCa cell growth, migration and invasion were significantly affected by EJCE. EJCE decreased expression of sterol regulatory element-binding protein-1 (SREBP-1) and fatty acid synthase (FASN) in PCa cells, two main factors for lipogenesis. By inhibiting SREBP-1/FASN, EJCE reduced the intracellular fatty acid levels and lipid droplet accumulation in PCa. Moreover, EJCE down-regulated the androgen receptor (AR) and prostate-specific antigen (PSA) in PCa cells. Significantly, EJCE exhibited the potential anticancer activity by suppressing the growth and leading to apoptosis of CRPC tumors in a xenograft mouse model. Conclusion: These results reveal a novel therapeutic molecular mechanism of EJCE in PCa. Blockade of SREBP-1/FASN-driven metabolism and AR by EJCE could be employed as a potent opportunity to cure malignant PCa.
    關聯: PHYTOMEDICINE, v.93, 153806
    顯示於類別:[藥學系(所)] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML184檢視/開啟
    j.phymed.2021.153806.pdf7714KbAdobe PDF229檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋